[go: up one dir, main page]

HK1024423A1 - Oxacarbazepine film-coated tablets - Google Patents

Oxacarbazepine film-coated tablets Download PDF

Info

Publication number
HK1024423A1
HK1024423A1 HK00103912A HK00103912A HK1024423A1 HK 1024423 A1 HK1024423 A1 HK 1024423A1 HK 00103912 A HK00103912 A HK 00103912A HK 00103912 A HK00103912 A HK 00103912A HK 1024423 A1 HK1024423 A1 HK 1024423A1
Authority
HK
Hong Kong
Prior art keywords
oxacarbazepine
particle size
film
median particle
sieve
Prior art date
Application number
HK00103912A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1024423B (en
Inventor
Schlutermann Burkhard
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4184588&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1024423(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1024423A1 publication Critical patent/HK1024423A1/en
Publication of HK1024423B publication Critical patent/HK1024423B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HK00103912.9A 1997-02-14 1998-02-12 Oxacarbazepine film-coated tablets HK1024423B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH33197 1997-02-14
CH331/97 1997-02-14
PCT/EP1998/000794 WO1998035681A1 (en) 1997-02-14 1998-02-12 Oxacarbazepine film-coated tablets

Publications (2)

Publication Number Publication Date
HK1024423A1 true HK1024423A1 (en) 2000-10-13
HK1024423B HK1024423B (en) 2003-12-05

Family

ID=

Also Published As

Publication number Publication date
BR9807368A (pt) 2000-03-14
ATE239481T1 (de) 2003-05-15
CY2480B1 (en) 2005-06-03
ID22348A (id) 1999-09-30
SK109899A3 (en) 2000-03-13
MY117582A (en) 2004-07-31
PL334959A1 (en) 2000-03-27
AU6622298A (en) 1998-09-08
HUP0000886A2 (hu) 2000-09-28
EP0966287B1 (en) 2003-05-07
TR199901804T2 (xx) 1999-09-21
JP2006077029A (ja) 2006-03-23
KR20120079826A (ko) 2012-07-13
PT966287E (pt) 2003-09-30
PL193332B1 (pl) 2007-02-28
KR19980071337A (ko) 1998-10-26
SK284503B6 (sk) 2005-05-05
JP2010132694A (ja) 2010-06-17
NO993919L (no) 1999-08-13
CA2277791C (en) 2008-11-18
HUP0000886A3 (en) 2002-10-28
DE69814367T2 (de) 2004-02-26
TW529957B (en) 2003-05-01
PE58999A1 (es) 1999-06-25
AR011142A1 (es) 2000-08-02
CN1170542C (zh) 2004-10-13
DE69814367D1 (de) 2003-06-12
CN1247471A (zh) 2000-03-15
KR20090037873A (ko) 2009-04-16
HU227807B1 (en) 2012-03-28
DK0966287T3 (da) 2003-08-25
US20070036863A1 (en) 2007-02-15
EP0966287A1 (en) 1999-12-29
NO327486B1 (no) 2009-07-13
CA2277791A1 (en) 1998-08-20
US20080014269A1 (en) 2008-01-17
JP2000511935A (ja) 2000-09-12
ZA981205B (en) 1998-08-14
RU2201218C2 (ru) 2003-03-27
ES2199422T3 (es) 2004-02-16
AU738030B2 (en) 2001-09-06
CO4920215A1 (es) 2000-05-29
WO1998035681A1 (en) 1998-08-20
CZ287999A3 (cs) 1999-11-17
UY24888A1 (es) 2000-12-29
NZ336946A (en) 2001-02-23
CN1626093A (zh) 2005-06-15
NO993919D0 (no) 1999-08-13
CZ298840B6 (cs) 2008-02-20

Similar Documents

Publication Publication Date Title
EP0966287B1 (en) Oxacarbazepine film-coated tablets
US7037525B2 (en) Oxacarbazepine film-coated tablets
AU777705B2 (en) Pharmaceutical compositions
CA2131495C (en) Double-layered oxcarbazepine tablets
HK1024423B (en) Oxacarbazepine film-coated tablets
NZ509391A (en) Oxacarbazepine film-coated tablets further comprising a hydrophobic permeable outer coating containing iron oxide from 0.3 to 0.9 mg per tablet
MXPA99007514A (en) Oxacarbazepine film-coated tablets

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140212